These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25720804)

  • 41. In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54.
    Kayser O; Kiderlen AF; Brun R
    Planta Med; 2001 Nov; 67(8):718-21. PubMed ID: 11731912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Further studies on the effect of antimalarial drugs against erythrocytic forms of Plasmodium gallinaceum in vitro.
    JOSEPHSON ES; TAYLOR DJ; GREENBERG J; COATNEY GR
    J Infect Dis; 1953; 93(3):257-62. PubMed ID: 13109240
    [No Abstract]   [Full Text] [Related]  

  • 43. The in vitro activity of certain antimalarials against erythrocytic forms of Plasmodium gallinaceum.
    TAYLOR J; JOSEPHSON ES; GREENBERG J; COATNEY GR
    Am J Trop Med Hyg; 1952 Jan; 1(1):132-9. PubMed ID: 14903443
    [No Abstract]   [Full Text] [Related]  

  • 44. Synthesis of Cyclic Peptides as Potential Anti-Malarials.
    Fagundez C; Sellanes D; Serra G
    ACS Comb Sci; 2018 Apr; 20(4):212-219. PubMed ID: 29446619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.
    Gelhaus C; Jacobs T; Andrä J; Leippe M
    Antimicrob Agents Chemother; 2008 May; 52(5):1713-20. PubMed ID: 18332165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptide derivatives specific for a Plasmodium falciparum proteinase inhibit the human erythrocyte invasion by merozoites.
    Mayer R; Picard I; Lawton P; Grellier P; Barrault C; Monsigny M; Schrével J
    J Med Chem; 1991 Oct; 34(10):3029-35. PubMed ID: 1920353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmodium gallinaceum infection characterized by predominance of exo-erythrocytic forms.
    HAAS VH; WILCOX A
    Public Health Rep (1896); 1946 Jun; 61():921-8. PubMed ID: 20987860
    [No Abstract]   [Full Text] [Related]  

  • 48. Observations on the pre-erythrocytic stages of Plasmodium relictum, Plasmodium cathemerium, and Plasmodium gallinaceum in various birds.
    HUFF CG
    J Infect Dis; 1951; 88(1):17-26. PubMed ID: 14803745
    [No Abstract]   [Full Text] [Related]  

  • 49. Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.
    Harris KS; Casey JL; Coley AM; Karas JA; Sabo JK; Tan YY; Dolezal O; Norton RS; Hughes AB; Scanlon D; Foley M
    J Biol Chem; 2009 Apr; 284(14):9361-71. PubMed ID: 19164290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malaria parasite Plasmodium gallinaceum up-regulates host red blood cell channels.
    Thomas SL; Egée S; Lapaix F; Kaestner L; Staines HM; Ellory JC
    FEBS Lett; 2001 Jun; 500(1-2):45-51. PubMed ID: 11434924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pumilacidins from the Octocoral-Associated
    Torres-Mendoza D; Coronado LM; Pineda LM; Guzmán HM; Dorrestein PC; Spadafora C; Gutiérrez M
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30158478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cultivation of the erythrocytic form of Plasmodium gallinaceum in tissue cultures of embryonic chicken brain.
    MEYER H
    Nature; 1947 Aug; 159(4057):155. PubMed ID: 20344386
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of pyrimethamine on the BI strain of Plasmodium gallinaceum.
    GREENBERG J; TREMBLEY HL; COATNEY GR
    Am J Trop Med Hyg; 1954 Jul; 3(4):665-71. PubMed ID: 13180825
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on Plasmodium gallinaceum in vitro. I. A method for maintenance of the erythrocytic parasite in vitro.
    TAYLOR DJ; GREENBERG J; JOSEPHSON ES; RAY AP
    J Infect Dis; 1951; 88(2):158-62. PubMed ID: 14832493
    [No Abstract]   [Full Text] [Related]  

  • 55. The glucose metabolism of Plasmodium gallinaceum, and the action of antimalarial agents.
    MARSHALL PB
    Br J Pharmacol Chemother; 1948 Mar; 3(1):1-7. PubMed ID: 18904718
    [No Abstract]   [Full Text] [Related]  

  • 56. Relationship between time of administration, dose, and prophylactic activity of pyrimethamine on sporozoite-induced Plasmodium gallinaceum infections.
    GREENBERG J; COATNEY GR; TREMBLEY HL
    Am J Trop Med Hyg; 1954 Jul; 3(4):672-5. PubMed ID: 13180826
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of pyrimethamine (daraprim) against Plasmodium gallinaceum infections in chicks.
    GREENBERG J; COATNEY GR; TREMBLEY HL
    Am J Trop Med Hyg; 1953 Sep; 2(5):771-6. PubMed ID: 13092365
    [No Abstract]   [Full Text] [Related]  

  • 58. The action of antimalarial drugs in mosquitoes infected with Plasmodium gallinaceum.
    TERZIAN LA; STAHLER N; WEATHERSBY AB
    J Infect Dis; 1949; 84(1):47-55. PubMed ID: 18109252
    [No Abstract]   [Full Text] [Related]  

  • 59. Response of exo-erythrocytic forms to alterations in the lifecycle of Plasmodium gallinaceum.
    HAAS VH; WILCOX A
    J Parasitol; 1947 Dec; 33(2):28. PubMed ID: 20271948
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei.
    SCHELLENBERG KA; COATNEY GR
    Biochem Pharmacol; 1961 May; 6():143-52. PubMed ID: 13747452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.